I couldn’t care less about Big Pharma’s TA charts. Rather, what piques my interest in Big Pharma stocks is that the valuations are cheap, the dividend yields are high and well covered, and the companies’ pipelines are better than many investors think.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.